Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Microwave Endometrial Ablation Compared With Rollerball In PMA Study

This article was originally published in The Gray Sheet

Executive Summary

FDA's Obstetrics & Gynecology Devices Panel will examine on June 10 the first microwave endometrial ablation device potentially available in the U.S. to treat menorrhagia, according to PMA sponsor Microsulis

You may also be interested in...



NICE Encourages Balloon, Microwave Endometrial Ablation In UK

Guidelines recommending endometrial ablation (EA) instead of hysterectomy for the treatment of menorrhagia could save the UK National Health System over $40 mil. annually, according to a National Institute for Clinical Excellence 1appraisal consultation document issued April 14

Separate APC Category For Thermal Ablation Not Appropriate – CMS Panel

CMS should avoid creating new APC categories under the hospital outpatient prospective payment system that are geared towards a specific device, the agency's APC Advisory Panel maintains

Atlas Biomed Unlocking Japan’s OTC Market With Direct-To-Consumer DNA And Microbiome Tests

Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus. 

UsernamePublicRestriction

Register

OM014142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel